Alopexy spray 2% bottle 3 x 60ml
Indications: Treatment of hair loss. Solution for cutaneous application.
1. NAME OF THE MEDICINE
ALOPEXY 2 PER CENT, solution for cutaneous application
Minoxidil ................................................................................................................................................ 2 g
Per 100 ml of solution for cutaneous application.
Notable excipient: propylene glycol
For a complete list of excipients, see section 6.1.
Solution for dermal application.
This medicine is indicated in the case of moderate hair loss (androgenetic alopecia) in adult men and women. It promotes hair growth and stabilises hair loss.
RESERVED FOR ADULTS.
Apply twice a day a dose of 1 ml to the scalp, starting from the centre of the area to be treated.
The daily dose should not exceed 2 ml.
Spread the product with the fingertips so as to cover the entire area to be treated.
Before and after applying the solution, wash your hands thoroughly.
Apply to perfectly dry hair and scalp.
Using the pipette
A pipette allows you to take precisely 1 ml of solution to be spread over the whole area to be treated.
Use of the pump with applicator:
Remove the cap of the bottle and unscrew the cap that closes the bottle.
Screw the dosing pump onto the bottle.
To apply: direct the pump towards the centre of the area to be treated, press once and spread the product with the fingertips so as to cover the entire area to be treated.
Repeat 6 times to apply a 1 ml dose.
Hypersensitivity to minoxidil or to any of the other components of the solution.
Before using topical minoxidil, the subject should ensure that the scalp is normal and healthy.
Increased percutaneous absorption of minoxidil, which may result in systemic effects, may occur in the case of:
- dermatosis or scalp injury,
- concomitant application of retinoic acid, anthralin or any other irritating topical,
- increase in the dose applied and/or increase in the frequency of applications: it is imperative to respect the dosage and the method of administration.
Similarly, although extensive use of minoxidil solution has not revealed any systemic effects, it cannot be excluded that increased absorption due to individual variability or unusual sensitivity may cause systemic effects. Patients should be advised of this.
If systemic effects (e.g., decreased blood pressure, tachycardia, signs of fluid retention, chest pain) or severe dermatologic reactions occur, treatment should be discontinued.
In patients with a history of heart disease, the benefit of treatment should be weighed. They should be particularly warned of potential adverse effects so that treatment can be discontinued at the onset of any of them and a physician notified.
Do not apply minoxidil:
- in cases of sudden hair loss, hair loss due to illness or medication,
- on another part of the body.
Precautions for use
Accidental ingestion may result in severe adverse effects (see section 4.9).
In the event of accidental contact with the eye, injured skin or mucous membranes, the solution (containing ethyl alcohol) may cause a burning sensation and irritation: rinse thoroughly with running water.
Sun exposure is not recommended when applying minoxidil.
This medicine contains propylene glycol and may cause skin irritation.
The data available to date do not suggest the existence of clinically significant interactions.
Studies in animals have not shown any teratogenic effect. In the absence of teratogenic effects in animals, a malformative effect in humans is not expected. Indeed, to date, substances responsible for malformations in humans have been shown to be teratogenic in animals in well-conducted studies in two species.
Clinically, there are currently no sufficiently relevant data to assess a possible malformative or fetotoxic effect of minoxidil when administered during pregnancy.
Therefore, as a precautionary measure, minoxidil should not be used during pregnancy.
When administered systemically, minoxidil passes into breast milk; therefore, the drug should be avoided in nursing mothers.
- Mostly minor skin reactions: local irritation with, in particular, scaling, erythema, dermatitis, dry skin, hypertrichosis (at a distance), burning and pruritus (particularly due to the presence of alcohol).
- More rarely: allergy (sensitivity, rhinitis, rash, generalized erythema, facial edema), dizziness, tingling, headache, weakness, neuritis, edema, taste alteration, ear infection (especially otitis externa), visual disturbances, eye irritation.
- Alopecia, irregular hair growth, chest pain, changes in blood pressure and pulse rate have been reported.
Liver abnormalities may occur.
- Due to the presence of propylene glycol, contact eczema may occur.
It should be noted, however, that these medical events, especially those that have been reported less frequently, have been reported without it being possible to establish formally the imputability to the treatment.
Accidental ingestion may cause systemic effects due to the vasodilatory action of minoxidil (5 ml of solution contains 100 mg of minoxidil, the maximum dose used for oral administration in adults treated for hypertension). Signs and symptoms of possible overdosage would be cardiovascular, with decreased blood pressure, tachycardia and fluid retention. Fluid retention may be treated with appropriate diuretic therapy, tachycardia and angina with a beta-blocker or other sympathetic nervous system inhibitor. Symptomatic hypotension may be treated by intravenous administration of isotonic sodium chloride solution. The use of sympathomimetics such as norepinephrine and adrenaline should be avoided because of excessive cardiac stimulation.
OTHER DERMATOLOGICAL DRUGS
ATC Code: D11AX01
Efficacy and safety in subjects under 18 and over 65 years of age have not been studied.
Applied topically, minoxidil stimulates keratinocyte growth in vitro and in vivo and hair growth in some subjects with androgenetic alopecia.
The onset of this phenomenon occurs after approximately 4 months (or more) of use and varies from subject to subject.
Upon discontinuation of treatment, regrowth ceases and a return to the initial state can be expected within 3 to 4 months.
The precise mechanism of action is not known. Topical application of minoxidil in controlled clinical trials in normotensive or hypertensive patients has not resulted in the observation of systemic events related to minoxidil absorption.
Minoxidil, when applied topically, is only poorly absorbed: an average of 1.4% (ranging from 0.3 to 4.5%) of the applied dose reaches the systemic circulation. Thus, for a dose of 1 ml of 2% solution (i.e. 20 mg minoxidil applied to the skin), the amount of minoxidil absorbed corresponds to approximately 0.28 mg.
In comparison, when given orally (in the treatment of certain hypertensive diseases), minoxidil is almost completely absorbed from the gastrointestinal tract. It has also been shown that the lowest dose of minoxidil administered I.V. that induces clinically significant hemodynamic effects in patients with mild to moderate hypertension is 6.86 mg.
The results of pharmacokinetic studies indicate that the three main factors that increase the absorption of topical minoxidil are
- quantitative increase in the applied dose,
- increased frequency of application,
- decrease in barrier function of the stratum corneum of the epidermis.
This increase is rapidly limited by a saturation effect.
Absorption of minoxidil after topical application is not affected by gender, UV exposure, simultaneous application of a moisturizer, occlusion (hair prosthesis), evaporation of the solvent (hair dryer), or surface area of application.
Serum minoxidil levels following topical administration are dependent on the rate of percutaneous absorption. After discontinuation of topical application, approximately 95% of absorbed minoxidil is eliminated within 4 days.
The biotransformation of absorbed minoxidil after topical application is not fully understood.
- Packaged in a bottle (brown glass): 3 years
- Bottle pack (PET): 2 years.
No special precautions for storage.
- Bottle (brown glass) of 15 ml, 30 ml or 60 ml with or without pipette (Polystyrene/polyethylene) graduated to 1 ml. Box of 1 or 3.
- 60 ml bottle (PET) with pipette (Polystyrene/polyethylene) graduated to 1 ml and dosing pump with applicator. Box of 1 or 3.
No special requirements.
PIERRE FABRE DERMATOLOGIE
45, PLACE ABEL GANCE
- 330 924-1: 15 ml bottle (brown glass) with pipette (polystyrene/polyethylene).
- 330 228-5: 30 ml in a bottle (brown glass) with pipette (polystyrene/polyethylene).
- 330 925-8: 60 ml in a bottle (brown glass) with pipette (polystyrene/polyethylene).
- 332 175-6: 2 vials (brown glass) of 60 ml + 1 vial (brown glass of 15 ml).
- 335 273-9: 60 ml bottle (brown glass) box of 3.
- 362 991-6: 60 ml bottle (PET) with pipette (Polystyrene/polyethylene) and dosing pump with applicator. Box of 1.
- 364 307-5: 60 ml bottle (PET) with pipette (Polystyrene/polyethylene) and dosing pump with applicator. Box of 3.
[To be completed by the holder]
[to be completed by the holder]
Add Other Product These products may interest you
This medicine is an anti-inflammatory and analgesic (pain reliever), in the form of a gel for application to the skin, only in the painful area.
This medicine is intended for adults (from 15 years old), for a short time, in :
- local treatment in case of benign trauma: sprain, contusion;
- local treatment of pain of muscular and tendino-ligamentary origin;
- the symptomatic treatment of the painful pushes of osteoarthritis, after at least a medical opinion.
Box of 1 Pressurized bottle of 100 ml
Indications : Short-term treatment of acute diarrhoea in adults (from 15 years). This treatment is a complement to dietary measures: read carefully the chapter "precaution of use".
Efferalgan 250 mg is an antipyretic and analgesic drug indicated in case of fever and/or mild to moderate pain such as headaches, aches, flu-like conditions or dental pain, in children weighing between 13 and 50 kg
Diclofenac Sandoz 1% gel is indicated in cases of tendonitis of the upper and lower limbs, post-operative and post-traumatic oedema. Diclofenac Sandoz 1% gel is indicated in the symptomatic treatment of painful osteoarthritis of the fingers and knees.
This medicine helps smokers to detoxify from tobacco. The chewing gum brings in the blood, by the intermediary of the saliva, the nicotine, principal active substance of the tobacco, responsible for theaddiction.
It is used either to stop smoking permanently or to stop temporarily.
To relax, nothing better than a massage!
syntholkiné is based on a traditional method, simple and natural, used by physiotherapists: the massage that promotes well-being through its soothing and relaxing.
The combination of the massage ball and essential oils gives you a pleasant warming sensation and thus promotes relaxation.
Indications: This medicine contains paracetamol. Pain and/or fever (headaches, flu, dental pain ...). For adults and children over 27kg (8 years and older). Children under 27kg, use other presentations of paracetamol.
Ristabil is a natural food supplement based on royal jelly, extracts of eleutherococcus (Siberian ginseng), bilberry and rosehip (Vitamin C) associated with vitamins of the B group.
The drug Fixical Vitamin D3 1000 mg / 800 IU, composed of calcium and vitamin D, is indicated in the elderly in case of calcium and vitamin D deficiency and in association with osteoporosis treatments when the intake of calcium and vitamin D is insufficient.
Fixical Vitamin D3 1000 mg / 800 IU is reserved for adults and children over 15 years.
Indications : ACTIRUB®* adult oral solution is a complex of active ingredients, including Chamomile which helps to soothe the throat and Eucalyptus essential oil which has a soothing effect on the throat & pharynx.
Exomuc 200 mg granules without water is a medicine indicated for recent respiratory disease, accompanied by difficulty in expectoration, that is, difficulty in evacuating bronchial secretions by spitting.
Indications: This medicine contains sulphur, vitamin A and yeast. This combination aims to reduce inflammation of the mucous membrane of the nose and throat. It is used in the adjunctive treatment of chronic rhinopharyngitis.
Description : Calmosine digestion is a digestive and soothing drink : Fennel improves digestive comfort, Lime blossom is known for its calming virtues, especially at the digestive level. Orange Blossom brings its delicate aroma to the formula.